Literature DB >> 32676908

Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?

Richard C Brunken1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32676908     DOI： 10.1007/s12350-020-02272-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

Review 1.  Evaluation of Known or Suspected Cardiac Sarcoidosis.

Authors:  Ron Blankstein; Alfonso H Waller
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

2.  Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.

Authors:  Tomas Vita; David R Okada; Mahdi Veillet-Chowdhury; Paco E Bravo; Erin Mullins; Edward Hulten; Mukta Agrawal; Rachna Madan; Viviany R Taqueti; Michael Steigner; Hicham Skali; Raymond Y Kwong; Garrick C Stewart; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  Circ Cardiovasc Imaging       Date:  2018-01       Impact factor: 7.792

3.  What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?

Authors:  Sang-Geon Cho; Hyung Yoon Kim; Hee-Seung Bom
Journal:  J Nucl Cardiol       Date:  2019-11-25       Impact factor: 5.952

4.  The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.

Authors:  R J Flores; K R Flaherty; Z Jin; S Bokhari
Journal:  J Nucl Cardiol       Date:  2018-11-12       Impact factor: 5.952

Review 5.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.